Hepato Renal Protective Effect of Origanum Majorana against Adverse Effect of Ivermectin in Rabbits
Research Article
Hepato Renal Protective Effect of Origanum Majorana against Adverse Effect of Ivermectin in Rabbits
Ahmed Mohamed Elmahdy1*, Naglaa Mohammed Alkalamawy2
1Department of Biochemistry, Toxicology and Feed Deficiency; 2Pathology Department-Molecular Pathology Unit, Animal Health Research Institute(AHRI), Agricultural Research Center (ARC), Giza, Egypt.
Abstract | The current study looked at the hepatic-renal protection of Origanum majorana “O.M” leaves extract in male rabbits against the negative effects of ivermectin. Twenty male rabbits were used and divided into four groups each group contain 5 rabbits as a following: Group one: rabbits which served as negative control were orally administered distilled water for 60 consecutive days. Group two: The rabbits in this group were given an aqueous extract of O.M. orally (200 milligrams per kilogram of body weight), once daily for 60 consecutive days. Group three: rabbits in this group received a subcutaneous therapeutic dose of ivermectin (200 micrograms per kilogram body weight), once monthly for 2 consecutive months. Group four: This group of rabbits was given an orally aqueous extract of O.M. (200 milligrams per kilogram of body weight) once daily for sixty consecutive days. and a subcutaneous therapeutic dose of ivermectin (200 micrograms per kilogram of body weight), once monthly for 2 consecutive months. The degree of hepatic protection was measured using liver enzymes activities (Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), alkaline phosphatase (ALP), g-Glutamyl transferase (GGT) and total bilirubin, also the levels of Cholesterol, Triglycerides, HDL-cholesterol, LDL- cholesterol and VLDL-cholesterol were also estimated. The degree of renal protection was measured using creatinine, urea, sodium, potassium, also the levels of total protein, Albumin and Globulin were quantitated also the histo-pathological examination of the liver, kidneys were done. Results showed that the administration of O.M. extract restored the severely disrupted liver and kidney functions caused by ivermectin’s unfavorable effect to almost normal levels as well as the co-administration of O.M. extract significantly reduced the histopathological effect of ivermectin on the liver and kidney. From our findings we concluded that the O.M. aqueous extract possessed a hepato-renal protective effect against ivermectin-induced adverse effects in rabbits.
Keywords | Hepato-renal, Ivermectin, Origanum Majorana, Rabbits
Received | March 04, 2022; Accepted | April 24, 2022; Published | June 20, 2022
*Correspondence | Ahmed Mohamed Elmahdy, Department of Biochemistry, Toxicology and Feed Deficiency, Animal Health Research Institute(AHRI), Agricultural Research Center (ARC), Giza, Egypt; Email: drahmedelmahdy7@gmail.com
Citation | Elmahdy AM, Alkalamawy NM (2022). Hepato renal protective effect of origanum majorana against adverse effect of ivermectin in rabbits. Adv. Anim. Vet. Sci. 10(7):1492-1503.
DOI | https://dx.doi.org/10.17582/journal.aavs/2022/10.7.1492.1503
ISSN (Online) | 2307-8316
Copyright: 2022 by the authors. Licensee ResearchersLinks Ltd, England, UK.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
INTRODUCTION
Avermectins have been first discovered as a macrocyclic lactone in the broth of a soil microorganism Streptomyces avermitilis. Avermectins consists of eight natural avermectin components A1a, A2b, A2a, A2b, B1a, B1b, B2a and B2b, the B series members were found very effective against helminthes and arthropods. Ivermectin [which its chemical structure is composed of a mixture of two compounds 22, 23 dihydroavermectin B1a (H2B1a), and 22, 23 dihydroavermectin B1b (H2B1b)], showed revolutionized antiparasitic control when being used in the treatment of animals and humans over the last decade (Steel, 1993; Shoop et al., 1995).
In humans, Ivermectin is used in the treatment of Onchocerciasis (river blindness), strongyloidiasis, Ascariasis, Trichuriasis, Filariasis, Enterobiasis, and Scabies (Bonerjee et al., 2009), while in animals it is used in the treatment and prevention of parasitic disease, it is even used as plant protection agents in the agricultural sector.
Although ivermectin appears to be a well-tolerated drug with no apparent adverse effect in mammals at pharmacological doses, (Castanha-Zanoli et al., 2012; Trailovic and Varagic, 2007) stated that the most prominent clinical signs of ivermectin poisoning in animals are CNS depression, coma and may be death. ivermectin induced pathological changes as neuronal degeneration and necrosis in pigeon brain tissue after sub chronic exposure to different doses of ivermectin for different periods (Ming et al., 2013). The repeated administration of different doses of ivermectin cause pathological changes in liver tissue of female rabbits as vacuolation of hepatocytes and fibrosis, the degree of affection depend on the given dose (Al-Jassim et al., 2015), ivermectin, when was given in therapeutic and double therapeutic doses to male rats, results in a significant decrease in total sperm count and mortality with pathological alternation in the liver, kidney, and testicles include blood vessels congestion, vascular and hydropic degeneration or necrosis and significant shift in liver and kidney functions (Elzoghby et al., 2015).
Traditional medical systems and some traditional medical procedures are now widely acknowledged in the world. Today, having a realistic approach and an analytical approach to testing drugs derived from herbs is essential.
As a result, Pharmacologists must receive a lot of knowledge from traditional healers concerning their treatments and the extraction of active principles for drug creation (Muthuraman et al., 2011).
Origanum spp. has been used as a spice and in ethno medicine for thousands of years (Fleisher and Fleisher, 1988). Its antifungal, antimicrobial, insecticidal, and anti-oxidant properties are all present (Kokkini, 1997; Baydar et al., 2004; Kulisic et al., 2004; Bakkali et al., 2008). Origanum spp. has been shown to have antispasmodic, antitumor, and analgesic properties (Elgayar et al., 2001; Puertas et al., 2002). It also causes the Inhibition of soybean lipoxygenase indicates that it has anti-inflammatory effects (Koukoulitsa et al., 2006).
This experiment was carried out to determine the effect of O.M. against the adverse effect of repeated therapeutic doses of ivermectin in rabbits.
MATERIALS AND METHODS
Materials
Ivermectin was obtained from the pharma swede company (Cairo, Egypt), as (paramectin® injection), each one ml containing 10 mg of ivermectin.
The fresh leaves of O.M. were gathered from a garden of the faculty of agriculture, Cairo University, Egypt. And undergo an extraction procedure according to (Roby et al., 2013). Briefly, the leaves of the plants were washed, dried in the shade for 20 days, and then powdered with an electric blender. The fine powder (250 g) was boiled in distilled water (1000 ml) for 90 minutes before being filtered through Whatman papers. To obtain a dry extract, the filtrated water extract was evaporated under low pressure and lyophilized. The dried residues were reconstituted in water to yield stock a solution containing 500 mg/ml. Filtration was used to sterilize the extracts. using Acrodisc (Gelman, 0.22 μm size) and then preserved in the refrigerator (4 °C) till be used.
Experimental rabbits
Twenty apparently healthy adult male New Zealand rabbits (weighing 1800-2000 g) were used. Rabbits were fed on concentrate pelleted ration and tap water which were provided ad libitum. Rabbits were housed in galvanized wire cages. Rabbits were accustomed to their surroundings for fourteen days before the beginning of the experiment. The experiment design and animal handling were approved by the research committee at the animal health research institute (AHRI), Agricultural research center (ARC).
Experimental protocol
At the beginning of the experiment, the rabbits were randomly grouped into four groups (each of 5 rabbits). Group one: Rabbits which served as the control was orally administered distilled water for 60 consecutive days; Group two: rabbits in this group received orally aqueous extract of O.M. (200 mg/kg b. wt.), once daily for 60 consecutive days and served as positive control group; Group three: rabbits in this group received a subcutaneous therapeutic dose of ivermectin (200 µg/kg b. wt.) (EMA, 2014), once monthly for 2 consecutive months; Group four: rabbits in this group received orally aqueous extract of Origanum (200 mg/kg b.wt.), once daily for 60 consecutive days and a subcutaneous therapeutic dose of ivermectin (200 µg/kg b. wt.), once monthly for 2 consecutive months.
Sampling
At the end of the experiment, blood samples for biochemical analysis were taken from the studied rabbits’ ear veins using a syringe and allowed to clot at room temperature. and then centrifuged (15 min, 3000rpm) then the obtained serum samples were stored at -20°C until the determination of biochemical parameters.
After humane end of the used rabbit by authentication (decapitation) which has been done according to protocol authorized by The Institutional Animal Care and Use Committee (ARC-IACUC)/Agricultural Research Center (ARC/AH/22/03), the liver and the 2 kidneys were collected and preserved in 10% formalin till histo-pathological examination.
Methods of biochemical analysis
Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) were quantitatively estimated according to the method described by (Reitman and Frankel, 1957; Young, 1997), Alkaline Phosphatase (ALP) was quantitatively estimated according to the method described by (Tietz, 1995), ɣ-Glutamyltransferase (ɣGT) (Szase, 1974), total bilirubin, (Tietz, 1995), Triglyceride (Wahlefeld, 1974). cholesterol (Watson, 1960). Albumin (Doumas et al., 1997). Total protein was estimated according to (Tietz,1994). Globulin level are estimated mathematically by subtracting albumin amount from total proteins amount, albumin: globulin ratio was calculated by dividing albumin amount by globulin amount (Tietz,1994). High-density lipoprotein (HDL) according to (Peace and Kaplan, 1987), serum urea level according to (Wybenga et al., 1971). Serum creatinine level according to (Tietz, 1986). Potassium was estimated according to (Hoeflmayr, 1979; Tietz, 1976) and sodium was estimated according to (Trinder, 1951; Tietz, 1976), very low density lipoprotein (VLDL) cholesterol was calculated by dividing the amount of triglycerides by 5 and low density lipoprotein (LDL) cholesterol was calculated by subtracting high density lipoprotein (HDL) cholesterol and very low density lipoprotein (VLDL) cholesterol from total cholesterol amount (Friedewald et al., 1972).
Statistics analysis
The obtained data from biochemical analysis were computerized and evaluated for statistical significance, standard error estimation, and variance according to ANOVA test and by using SPSS 20. Duncans test of homogeneity was used to estimate the similarities for each group separately. All the results were expressed as a mean ±SE.
Method of histo-pathological examination
Hepatic and renal tissue specimens from different investigated groups which have been preserved in 10% formalin will be examined according to (Suvarna et al., 2012). Another set of tissue sections on the positively charged slide for IHC. Tissue sections were investigated using primary antibody of PECAM-1 and Avidin-biotin-peroxidase complex kit (Vectastain ABC Kit Standard, VectorLaboratories), were used according to the manufacturer’s instruction protocol.
RESULTS and dsicussion
Biochemical analysis
Table 1 showed that repeated therapeutic subcutaneous injection of ivermectin significantly increased the serum levels of Aspartate aminotransferase, Alanine aminotransferase, alkaline phosphatase, g-Glutamyl transferase, and total Bilirubin in group three as compared with group one.
The data also showed no significant differences in Aspartate aminotransferase, Alanine aminotransferase, alkaline phosphatase, g-Glutamyl transferase and total Bilirubin levels between group four and group one. The data illustrated also did not show any significant differences between group two as compared with the control group.
Table 2 showed that repeated therapeutic subcutaneous injection of ivermectin non-significantly decreases the cholesterol, triglycerides and non-significantly increase HDL-Cholesterol serum levels between group three and group one, the data also showed no significant difference in cholesterol and HDL-cholestrol levels and a significant difference in Triglycerides levels between group four and group one. The data illustrated also did not show any significant differences between group two as compared with group one (the control group).
In Table 3 there was a significant increase in creatinine, urea and potassium levels and a non-significant increase in sodium level in group three as compared with group one while there were no significant differences in all parameters between all other groups and group one (control group).
Table 4 showed that therapeutic subcutaneous injection of ivermectin significantly increased the serum level of total protein and albumin between group three and group one while no significant difference was observed in of total protein and albumin level between all other groups as compared to group one.
Histopathological study
Macroscopic investigation did not detect noticeable changes in the livers and kidneys of the different investigated groups.
Microscopic investigation revealed the following histopathological changes; both of control negative group1 and group 2 exhibited normal histological architectures in both hepatic and renal tissues. Group 3 revealed moderate dilation of peri-glomerular space with noticeable number of fragmented glomeruli, while others appeared collapsed
Table 1: Effect of O.M. aqueous extract of 200 mg/kg and/or ivermectin (200 µg/kg) on AST, ALT, ALP, GGT and Total Bilirubin concentration in serum of rabbits (Liver function test).
Parameters/ groups |
Aspartate aminotransferase (AST) (U/L) |
Alanine aminotransferase (ALT) (U/L) |
alkaline phosphatase (ALP) (U/L) |
g-Glutamyl transferase (GGT) (U/L) |
Total Bilirubin (mg/dl) |
Group one |
16±0.32ab |
8±0.56ab |
137±4.49a |
8.5±0.22a |
0.54±0.027ab |
Group two |
17±0.55b |
7±0.45a |
138±5.61a |
8.7±0.35a |
0.56±0.031ab |
Group three |
19±0.84c |
11±0.52c |
157±5.56b |
10.8±0.66b |
0.68±0.019c |
Group four |
16±0.71ab |
8.5±0.34b |
138 ±3.44a |
8.6±0.40a |
0.57±0.021b |
* Results are expressed as means ± SE (n =5), Anova test; * Values with different superscript litters within different rows differed significantly at (P≤0.05) according to Duncans test.
Table 2: Effect of O.M. aqueous extract of 200 mg/kg and/or ivermectin (200 µg/kg) on Cholesterol, Triglycerides, HDL-Cholestrol, LDL-Cholestrol, VLDL-Cholestrol concentration in serum of rabbits (lipid profile).
Parameters/ groups |
Cholesterol (mg/dl) |
Triglycerides (mg/dl) |
HDL-Cholestrol (mg/dl) |
LDL-Cholestrol (mg/dl) |
VLDL-Cholestrol (mg/dl) |
Group one |
172±5.15a |
105.4 ±2.73b |
58.2± 1.02a |
92.72 |
21.08 |
Group two |
167±3.8a |
102 ± 2.81ab |
59 ± 5.92a |
87.6 |
20.4 |
Group three |
165±7.58a |
99 ± 4.23ab |
67 ± 5.24a |
78.2 |
19.8 |
Group four |
161±5.51a |
92 ± 5.69 a |
59 ± 2.59a |
83.6 |
18.4 |
* Results are expressed as means ± SE (n =5), Anova test; * Values with different superscript litters within different rows differed significantly at (P≤0.05) according to Duncans test.
Table 3: Effect of O.M. aqueous extract (200 mg/kg), mg/kg B. Wt., and ivermectin (200 µg/kg) on creatinine, urea, sodium and potassium concentration in serum of rabbits (kidney function test).
Parameter/ groups |
Creatinine (mg/dl) |
Urea (mg/dl) |
Sodium (mmol/l) |
Potassium (mmol/l) |
Group one |
1.47±0.107a |
50.5±2.17a |
155±1.00ab |
5.35±0.11a |
Group two |
1.50±0.169a |
51±0.95a |
154.4±1.29a |
5.35±0.14a |
Group three |
1.94±0.167b |
56.8±1.32b |
156 ± 1.03b |
6±0.38b |
Group four |
1.45±0.0481a |
45.5±1.75a |
154 ± 0.93a |
5.3±0.1a |
* Results are expressed as means ± SE (n =5), Anova test; * Values with different superscript litters within different rows differed significantly at (P≤0.05) according to Duncan´s test.
Table 4: Effect of O.M. aqueous extract of 200 mg/kg and/or ivermectin (200 µg/kg) on total protein, albumin, globulin concentration and albumin: globulin ratio in serum of rabbits.
Parameters/ groups |
Total protein (gm/dl) |
Albumin (gm/dl) |
Globulin (gm/dl) |
Albumin globulin ratio |
Group one |
7.9 ± 0.47b |
3.5±0.237b |
4.4 |
0.8 |
Group two |
7.58 ± 0.09b |
3.30±0.11b |
4.28 |
0.77 |
Group three |
6.2 ± 0.25a |
2.5±0.217a |
3.7 |
0.68 |
Group four |
7.8 ± 0.26b |
3.4±0.06b |
4.4 |
0.77 |
* Results are expressed as means ± SE (n =5), Anova test; * Values with different superscript litters within different rows differed significantly at (P≤0.05) according to Duncan´s test.
and degenerated (Figure 1). Group 4 revealed restoration in the reno-pathological changes including peri-glomerular dilation and diminish in the incidence the glomerular tuft degeneration (Figure 2).
Regarding to Platelet endothelial cell adhesion molecule-1 (PECAM-1); group 1 and 2 showed expression of PECAM-1 in the glomerular tufts membrane (Figure 3a and b). Group 3 manifested loss of PECAM-1 expression in a significant number of glomerular tufts associated with increase in the tubular epithelial reactivity for PECAM-1 (Figure 3c). In group 4, restoration of PECAM-1 expression at a significant degree in the glomerular tufts and to some degree in the interstitial endothelial (Figure 3d) was detected.
Hepatic parenchyma showed normal histological criteria in control negative group 1. Group 2 showed mild degree of hydropic degeneration of hepatocytes radiated from central vein and associated with dilation of hepatic sinusoids in some areas (Figure 4). Group 3 showed marked dilation of hepatic sinusoids associated with distortion of hepatic cords in addition to fibrosis of portal area (Figure 5), some areas showed massive hydropic degeneration of hepatocytes. Group 4, despite dilation of hepatic sinusoids, the hepatic cords preserve its integrity (Figure 6).
PECAM-1 expression was absent in group 1 (Figure 7a), group 2 revealed minute expression of PECAM-1 at the margin of some dilated hepatic sinusoids (Figure 7b). Group 3 revealed intense expression of PECAM-1 at the margin of the markedly dilated hepatic sinusoids (Figure 7c). Meanwhile; weak expression of PECAM-1 in investigated hepatic parenchyma of group 4, even at the margin of scarcity dilated hepatic sinusoids (Figure 7d).
Dermatological diseases are among the most common clinical entities in household pets and fur-bearing animals (Deshmukh et al., 2010). External parasite infestation is one of the most prevalent and serious dermatological issues in rabbits (Darzi et al., 2007). It is the most stubborn, persistent, and zoonotically significant infectious disease (Kumar et al., 2002). Clinically, it is distinguished by pruritis, baldness, and prolonged illness and death as a result of cachexia (Roy et al., 2001). In the farms, ivermectin is the most commonly used antiparasitic drug across Egypt. Many kinds of research advised repeated administration of ivermectin dose as an effective curative protocol in rabbits affected with mange (Panigrahi and Gupta, 2013; Darzi et al., 2007; Mitra et al., 2014; Bharath et al., 2016) so a further investigation should be done to discover a hepato-renal protective agent to counter the adverse effect of repeated administration of ivermectin on liver and kidney.
The biochemical analysis
The serum biochemical markers are thought of as an internal mirror that shows the true impact of drugs such as the repeated dose of ivermectin and the herb marjoram as a counter on the liver and kidneys. The biochemical parameters that were measured were as follows: AST, ALT, ALP, GGT, total bilirubin, Cholesterol, Triglyceride, Albumin, Globulin, total protein, HDL-cholesterol, LDL- cholesterol, VLDL-cholesterol, creatinine, urea, sodium, potassium.
The present work showed no significant differences in all aforementioned biochemical parameters between group two (positive control group) and group one which consequently indicated no adverse effect of the O.M. when being used in the rabbits by a daily dose 200mg/kg b.wt. for 60 consecutive days, similar results were demonstrated by (Soliman et al, 2019) who used rats which have been received orally aqueous extract of organium (200 mg/kg), once daily for 30 consecutive days, (Nashwa and Faten, 2014) who used a daily dose of marjoram oil in rats for 2 months and (El-Shafeey and Taha, 2013) who used a daily dose of oregano water extract in female rats for 14 days.
ALT and AST are sensitive biomarkers that are directly engaged in liver damage and toxicity (El-demerdash, 2004). The increase in serum ALT and AST levels could be related to hepatotoxicity caused by increased hepatocyte cells membrane permeability or even rapture, resulting in enzyme leakage into the bloodstream (Rabab et al., 2015).
In the current research (Table 1) biochemical analysis indicated significant elevation in ALT, AST, and ALP in group three in comparison with group one. Such results demonstrated the adverse effect of ivermectin on the liver tissue agrees with those are mentioned by other researchers about the microcyclic lactones reverse effect on rabbits (El Far, 2013; Seddiek et al., 2013; Ismaiel et al., 2017) and rats (Arise and Malomo, 2009; Shoeb, 2013; Rabab et al., 2015).
Ivermectin is a relatively safe anti-parasitic treatment for animals, but, it may influence the balance of oxidants and antioxidants (El-Shenawy, 2010). Ivermectin can generate free radicals, which can have a deleterious effect on the parasite. Nitric oxide is engaged in a variety of physiological activities along the journey. Through its cytotoxic impact, it works as a free radical and as a host defense mechanism (Tamarozzi et al., 2011). Ivermectin was reported to counteract against scabies agents by inducing free radicals associated damage and by decreasing antioxidant enzyme activity (Behera et al., 2011).
The nearly normal levels in the serum ALT, AST, and ALP in group four (Table 1) suggest a reasonable hepatoprotective effect of this treatment, reduce the damage of plasma membrane of these tissues at a cellular level leading to decrease efflux of these enzymes into the extracellular fluid and bloodstream.
Such result agrees with those are mentioned by other researchers which demonstrated the hepatoprotective effect of O.M. on the liver tissue against other hepatotoxic substances in rats such as sodium nitrite (Nashwa and Faten, 2014), CCL4 (El-Shafeey and Taha, 2013), and paracetamol (Soliman et al., 2019), this result may be attributed to the presence of a high concentration of phenol in O.M and that is the reason which gives it the unique antiradical and antioxidant activities (Soliman et al., 2019; Chishti et al., 2013).
The present study showed significant increases in GGT in group three as compared to group one (control group), this increase may be attributed to degenerative and necrotic changes in the epithelial lining of the bile duct (Allam et al., 2020), also the maintaining of GGT serum level in group four near to normal level (which was demonstrated in group one) was observed and illustrated a reasonable protective effect of O.M against the adverse degenerative effect of repeated s/c ivermectin injection.
In vertebrates, bilirubin is a yellow molecule that arises in the normal catabolic process that breaks down heme. This catabolism is a crucial process in the body’s elimination of waste materials produced by the destruction of aging or dysfunctional red blood cells (Braunstein, 2019). According to our findings, liver cell death inhibits I bilirubin hepatic absorption, decreases conjugation, and prevents d-bilirubin excretion. Darwish and Eldakroury (2020) which caused a significant elevation of serum total bilirubin concentration in group three as compared to group one, the protective effect of O.M reduce liver cell destruction and succeeded to restore serum total bilirubin level near its normal level (control group).
In the present investigation, Injection of ivermectin into rabbits at a rate of 200 micrograms per kilogram of body weight monthly for two months resulted in a considerable increase in blood urea and creatinine levels; a similar increase in urea and creatinine levels following ivermectin injection has been documented by other researchers such as (Arise and Malomo, 2009). These elevations may be attributable to the direct influence of ivermectin or its metabolites on renal tissue. The increase in creatinine and urea concentrations in ivermectin-treated animals may be related to a decrease in glomerular renal filtration or renal tubule malfunction (Walmsley and White, 1994).
Ivermectin, which was discovered to significantly reduce the total body’s antioxidant capacity and to increase the production of nitric oxide (Atakisi et al., 2009), which can harm the renal tissue, leading to kidney malfunction. Failure in the glomerular filtration results in the retention of substances such as urea and creatinine, which may be responsible for their high serum levels in group three in comparison with group one (Selvakumar et al., 2013).
O.M. genus is a plant that has shown to possess several types of biological activities such as, antiradical activity and it is a rich source of polyphenols which are known natural antioxidants (Chishti et al., 2013) which can tolerate increment in the production of nitric oxide and compensate the reduction of total body’s antioxidant capacity caused by ivermectin which may be the cause of O.M. renal protective effect and can be observed as a maintaining in serum urea and creatinine levels in group four near-normal levels which have been observed in group one.
As is well known, the functional capacity of the kidney can be assessed by measuring sodium and potassium levels in the serum and excretory constituent concentrations (Whelton et al., 1994). Sodium and potassium are abundant in the body’s extracellular and intracellular fluids. They are the most essential components in the transport of electrolytes between the extracellular and intracellular compartments due to their propensity to rapidly break down into their constituent ions or radicals. The significant increase in serum Na+ concentration after ivermectin administration once a month for two months could be attributed to increased production of aldosterone (which has been shown to stimulate membrane aldosterone receptors) and other mineralocorticoids that increase tubular reabsorption of Na+ (Tietz et al., 1994).
As well as the considerable increase in serum K+ concentration in the ivermectin-treated group could be attributed to enhanced sensitivity of the nephron to aldosterone and other mineralocorticoids, which are responsible for electrolyte reabsorption and retention, respectively. this result agrees with what has been mentioned before by (Arise and Malomo, 2009) who used male albino rats which received a therapeutic dose of 0.4 milligram per kilogram of body weight ivermectin daily for 15 days, in our study the administration of O.M. with ivermectin succeeded to keep the levels of Na and K near normal levels which have been recorded in group one and this may be attributed to the ameliorative effect of the plant extract on kidneys.
Liver insufficiency in combination with ivermectin as a Farnesoid X receptor (FXR) ligand may be the cause of the non-significant decrease of cholesterol and triglyceride serum concentration levels in group three in comparison with group one, this result agreed with (Chahrazed et al., 2020) who demonstrated that ivermectin administration provoked a decrease in cholesterol and triglyceride in Healthy male young Algerian rabbits, (Jin et al., 2013) revealed that ivermectin reduced serum cholesterol in mice, which is attributed to the fact that the antiparasitic drug, ivermectin, is a Farnesoid X receptor (FXR) ligand that maintains bile acid and cholesterol homeostasis and can effectively improve hyperglycemia and hyperlipidemia in diabetic mice models by regulating gene expression.
The usage of O.M in combination with ivermectin (group 4) slightly decrease the serum cholesterol and triglycerides levels than levels in group 3 and this may be attributed to the combination between ivermectin as a Farnesoid X receptor (FXR) ligand and the anti-hyperlipidemic effect of O.M., such result agreed with what have mentioned by (Pimple et al., 2012) who mentioned that the oral administration of aqueous extract of O.M. in a dose of 200 milligrams per kilogram of body weight succeeded to restore the lipid values to normal in non-insulin dependent diabetes mellitus rats even more significantly than the hydro distilled volatile oil, the petroleum ether extract and the methanolic extracts which have been used in concentrations of 100, 200, 400 milligrams per kilogram of body weight.
There was a non-significant increase in HDL-Cholesterol serum level in group three in comparison to group one, this result agrees with (Chahrazed et al., 2020) who demonstrated that ivermectin treatment decreased all lipid parameters except HDL-C, which increased at 14 days. this level has been maintained near to normal level in the fourth group, such result agrees with what was mentioned by (Soliman et al., 2019) who mentioned that O.M. when used with paracetamol toxicity, succeeded to maintain HDL-Cholestrol serum level which has been recorded in paracetamol treated group of rats near to normal level.
Liver disorders and malfunction is also a big factor because albumin and globulin are made in the liver, so any disorder that affects the liver may reduce albumin and globulin production (Spinella et al., 2016). Other health condition like kidney disorders may also results in reduction of albumin and globulin production (Levitt and Levitt, 2017).
In our study, there was a significant decrease in albumin, total protein and subsequently decrease in the level of calculated globulins and A/G ratio in group three in comparison with group one which may be attributed to liver and kidney affections.
this decrease has been maintained near to normal level by using O.M in group four, such results agreed with (El-Speiy et al., 2016) who treated rabbits with ivermectin injection by double therapeutic dose 1 mg kg-1 of ivermectin via subcutaneous injection.
Histopathological study
This study aimed to detect the possible hazardous effect of ivermectin on rabbit kidneys and liver criteria and investigate the ability of O.M. to restore renal and hepatic histological criteria with concern for vascular integrity.
Despite of the known safety profile of ivermectin, within the recommended dose, for cheyletiellosis in rabbits (Mellgren and Bergvall, 2008); but ivermectin-related serious adverse drug reactions (sADRs) including toxidermia, renal and hepatic disorders had been recorded (Campillo et al., 2021). Ivermectin is extensively metabolized by human liver microsomes via cytochrome. So, ivermectin and its metabolites were excreted mainly in feces (Gonzalez et al., 2008) and less than 1% in urine (Mathachan et al., 2021).
Regarding to our histopathological investigation, there was dilation of periglomerular space indicate to increase in glomerular tuft vascular permeability ; this was detected in group 3 and restored in group 4; with suggestion to pathophysiological effect mediated by glomerular vascularity dysfunction.
PECAM-1 is a marker for blood vessels permeability modification with indication of transfer from fenestration to capillarization and hence loss of physiological function. The angiogenic effect of PECAM-1 is tissue specific and the endothelial proliferation depend on the level of PECAM-1 (Tsuneki and Madri, 2014).
PECAM-1 had a principal role in normal kidneys’ endothelial cells adhesion and migration, hence establishment of kidneys’ vasculature physiology require vasculogenesis and angiogenesis (Kondo et al., 2007). In normal kidneys, PECAM-1 is expressed in glomerular tufts and interstitial peritubular endothelial cells, this expression gets lost in case of sclerotic and /or fibrotic conditions (Sivridis et al., 2003).
In the present investigation PECAM-1 expression showed; marked loss in group 3 and re-expression was noticed in group 4.
Loss of PECAM-1 expression in some glomerular tufts of treated group (4) could be attributed to vasculopathy of some glomeruli. Meanwhile expression of PECAM-1 by tubular epithelium could be an indicator for release of PECAM-1 from fragmented glomerular endothelial cells after glomerular damage and subsequent uptake by tubular epithelia (Sivridis et al., 2003).
Permeability leakage appeared only following endothelial contraction and the restoring of microvascular integrity is dependent on PECAM-1– induced glycolytic response that reestablish cytoskeletal remodeling and junctional repair. High extracellular glucose level with further increase in ROS; lead to podocytes apoptosis and hence permeability impairment (Susztak et al., 2006).
Other factor that could affect the blood vessels function is oxidative stress which, leads to lipid peroxidation and impairment of cell membrane functions. Origanum (O. vulgare) possess nephron-protective effect through its anti-inflammatory and anti-oxidant activities mediated by increase Nrf2 and subsequent increase the intra-cellular level of SOD and CAT (Lui et al., 2017). On contrary; high dose of Orignum (800mg/kg) showed nephropathy effect with high urea and creatinine levels (Sharifi-Rigi et al., 2019).
Glomerular PECAM-1 expression is decreased with disordered glomerular architectures, and increase during recovery phase (Khan et al., 2011), that in accordance with our result as PECAM-1 expression reduced in group 3 and restored in group treated with O.M. (group 4).
Hepatic sinusoids are fenestrated blood vessels, under some pathological stats they undergo capillarization with loss of fenestration as an early stage of fibrosis associated by angiogenesis and finally capillarization (Baiocchini et al., 2019). Capillarization of hepatic sinusoids could explain their dilation and subsequent disorganization of hepatic cord; this feature was noticeable in group 3 (ivermectin).
Hepatic sinusoidal expression of PECAM-1 indicates to sinusoidal capillarization, reduction of cellular fenestration with deposition of basement membrane (Coulevard et al., 1993) and abnormal differentiation of pre-existing sinusoids (Schaffner and Popper, 1963); this expression was detected in group 2 and 3 at mild to severe degree respectively and almost lost in group 4 (O.M. + ivermectin) indicating to re-establishment of sinusoidal physiology with loss of PECAM-1 expression but persistence of abnormally proliferated/ dilated sinusoids as previously mentioned by Schaffner and Popper (1963) and indicated as irreversible changes by Wikinson et al. (2020).
Our study detected marked hazardous effect of ivermectin on hepatic sinusoids, this vasculopathology had an effect on the small blood vessels and hence the tissues supplied by them (Wani et al., 2017). This effect was also demonstrated in group 3, while restoration of hepatic sinusoids integrity was evident in groups 4.
Vascular property changes could also be attributed to the effect of nitric oxide. Nitric oxide (NO) molecules participate in regulation of vascular tone, remolding, endothelial permeability and angiogenesis through its regulation of endothelial cells survival, proliferation and migration. Endothelial NOS (eNOS) is the NO synthase (NOS) in endothelial cells (Gover et al., 2002).
Other possible role of Origanum Majoranum Extract (OME) is the ability to restore renal and hepatic pathy through up - regulation of lipid and glucose metabolic responsible genes mainly of adiponectin and GLUT2. Badran et al. (2019) report that OME induce, in dose dependent, relaxation of endothelium intact rings via enhancing the conversion of NO production by endothelial NO synthase (eNOS) with end result of vasodilator effect, quenching of free radicals with further anti-hypertensive effect (Peixoto-Neves et al., 2010). The vasodilator effect of adiponectin is mediated by the biosynthesis of eNO from NO that induced by high glucose concentration and is associated with reduction in PECAM-1 expression (Lee et al., 2015).
PECAM-1 affect vasodilation is mediated by NO. PECAM-1 is participated in intra-cellular eNOS expression and activities, so it is an essential agent in angiogenesis, vascular development and integrity, PECAM-1 expression may contribute to appropriate activation of eNOS (Park et al., 2015). But the effect of PECAM-1 deficiency on eNOS expression is tissue dependent (Dimaio et al., 2008).
Moreover, carvacrol and thymol, the main polar phenols of OME, possess antagonistic effects, anti-oxidative and irritant effects, respectively; so they suggested to restore hepato-pathic effect mainly through the anti-oxidative effect (Rašković et al., 2015). Both act as an initiator of cell proliferation and even liver regeneration (Abdel-Aziem et al., 2014). Capillarization of Liver sinusoidal endothelial cells (LSEC) associated with increase in expression of PECAM-1 and characterized by loss of sinusoidal endothelial cells fenestration and basement membrane synthesis and hence adopt capillary like phenotype which is irreversible (Wikinson et al., 2020).
CONCLUSIONs and Recommendations
In the current study, it was discovered that O.M. extract restores all of the ivermectin affected serum biochemical parameters to near-normal levels, and also that the O.M protective effect is mediated by vascular integrity with variable mediators and pathways. Thus, its aqueous extract exhibits a protective effect that reduces the hepato-renal adverse effects generated by the repeated use of ivermectin, implying its usage as a strong hepatoprotective and nephroprotective agent.
ACKNOWLEDGMENTs
We would like to thank Prof. Dr. Mahmoud Arafa and Prof. Dr. Mogda Kamel Mansour for reviewing this research
Novelty Statement
This research paper is considered one of the first studies which demonstrated the hepato-renal protective effect of O.M. which in turn could provide more information about its ability to counter the adverse effects of ivermectin which are generated by its repeated use in animals treatment.
Author’s Contribution
Both authors participated in design, experimental procedure, writing, revising , and reviewing of the manuscript
Conflict of interest
The authors have declared no conflict of interest.
REFERENCES
Abd-Elaziem SH, Hassan AM, El-Denshary ES, Hamzawy MA, Mannaa FA, Abd-Elwahhab MA (2014). Ameliorative effects of thyme and calendula extracts alone or in combination against aflatoxins-induced oxidative stress and genotoxicity in rat liver. Cytotechnology, 66(3): 457-470. https://doi.org/10.1007/s10616-013-9598-7
Al-Jassim AB, Jawad HA, Al-Asoudi E, Jeedkhadim S (2015). Biochemical and histological alterations in the liver due to repeated administration of ivermectin alone or with combination of vitamin C in local female rabbits. J. Int. Acad. Res. Multi., 3: 349-364. https://doi.org/10.12816/0034951
Allam T, Abd-Elgaber M, Nahed T, Abou-Laila M, Elkhatam A (2020). Clinicopathological effects of diclazuril prophylaxis and treatment on rabbits experimentally infected with Eimeria stiedae. Dam. J. Vet. Sci., 4(1): 20–28.
Arise RO, Malomo SO (2009). Effect of ivermectin and albendazole on some liver and kidney function indices in rat. Afr. J. Biochem. Res., 3: 190-197.
Atakisi E, Atakisi O, Topcu B, Uzun M (2009). Effect of therapeutic dose of ivermectin on plasma nitric oxide and total antioxidant capacity in rabbits. Eur. Rev. Med. Pharmacol. Sci., 13: 425-429.
Badran A, Baydoun E, Samaha A, Pintus G, Mesmar J, Iratni R, Issa K, Eid AH (2019). Marjoram relaxes rat thoracic aorta via a PI3-K/eNOS/cGMP Pathway. Biomolecules, 9(6): 227. https://doi.org/10.3390/biom9060227
Baiocchini A, Del-Nonno F, Taibi C, Visco-Comandini U, D’Offizi G, Piacentini M, Falasca L (2019). Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C. Sci. Rep., 9(1): 8760. https://doi.org/10.1038/s41598-019-45114-1
Bakkali F, Averbeck S, Averbeck D, Idaomar M (2008). Biological effects of essential oils. A review. F. Chem. Toxicol., 46: 446-475. https://doi.org/10.1016/j.fct.2007.09.106
Baydar H, Osman S, Ozkan G, Karadoa T (2004). Antibacterial activity and composition of essential oils from Origanum, Thymbra and Satureja species with commercial importance in Turkey. Food Contr., 15: 169-172. https://doi.org/10.1016/S0956-7135(03)00028-8
Behera SK, Dimri U, Singh SK, Mohanta RK (2011). The curative and antioxidative efficiency of ivermectin and ivermectin + vitamin E-selenium treatment on canine Sarcoptes scabiei infestation. Vet. Res. Commun., 35: 237-244. https://doi.org/10.1007/s11259-011-9468-8
Bharath Krc, Amaravathi M, Jyosthna S (2016). Clinico-Therapeutic management of Sarcoptic mange in a Rabbit. Int. J. Adv. Res. Biol. Sci., 3(4): 42-44.
Bonerjee P, Bhattacharyya N, Bhattacharjee S, Boujedaini AR, Khuda-Bukhsh B (2009). Ascorbic acid combats arsenic induced oxidative stress in mice liver. J. Ecotox. Environ. Saf., 72: 639-644. https://doi.org/10.1016/j.ecoenv.2008.07.005
Braunstein E (2019). Overview of hemolytic anemia hematology and oncology. In: Merck Manuals, Merck and Co., Inc., Kenilworth, NJ, USA, Professional Edition (in Latin).
Campillo JT, Boussinesq M, Bertout S, Faillie JL, Chesnais CB (2021). Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the world. PLoS Negl. Trop. Dis., 15(4): 1-18. https://doi.org/10.1371/journal.pntd.0009354
Castanha-Zanoli JC, Maioli MA, Medeiros HC, Mingatto FE (2012). Abamectin affects the bioenergetics of liver mitochondria: A potential mechanism of hepatotoxicity. Toxicol. In Vitro, 26: 51-56. https://doi.org/10.1016/j.tiv.2011.10.007
Chahrazed M, Hassina K, Soumya B, Dalila T, Asma B, Meriem B, Nacira DZ (2020). Beneficial effects of ascorbic acid on ivermectin repeated high-dose therapy in rabbits: biochemical and histopathological investigations. Eur. J. Biol. Res., 11: 1-13. https://doi.org/10.21608/eajbsd.2021.164581
Chishti S, Kaloo ZA, Sultan P (2013). Medicinal importance of genus Organium majorana: A review. J. Pharmacogn. Phytother., 5(10): 170-177.
Coulevard A, Scoazec JY, Feldmann G (1993). Expression of cell-cell and cell-matrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver. Am. J. Pathol., 143(3): 738–752.
Darwish AA, Eldakroury MF (2020). The effect of ivermectin injection on some clinicopathological parameters in camels naturally infested with scabies. Adv. Anim. Vet. Sci., 8(2): 34-40. https://doi.org/10.17582/journal.aavs/2020/8.s2.34.40
Darzi MM, Mir MS, Shahardar RA, Pandit BA (2007). Clinicopathological, histochemical and therapeutic studies on concurrent Sarcoptic and notoedric acariosis in rabbits. Vet. Arhiv., 77: 167–175.
Deshmukh VV, Varshney JP, Chaudhary PS, Desai SN (2010). Clinical management of scabies in rabbit bunnies. Intas. Polivet., 11: 112 –114.
Dimaio TA, Wang S, Huang Q, Scheef EA, Sorenson CM, Sheibani N (2008). Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice. Dev. Biol., 315: 72–88. https://doi.org/10.1016/j.ydbio.2007.12.008
Doumas BT, Watson WA, Biggs HG (1997). Albumin standards and the measurement of serum albumin with bromcresol green. Clin. Chim. Acta, 258: 21-30. https://doi.org/10.1016/S0009-8981(96)06447-9
El-Demerdaswh FM (2004). Antioxidant effect of vitamin E and selenium on lipid peroxidation, enzyme activities and biochemical parameters in rats exposed to aluminum. J. Trace Elem. Med. Biol., 18: 113-121. https://doi.org/10.1016/j.jtemb.2004.04.001
El-Far AH (2013). Effect of therapeutic and double therapeutic dose of ivermectin on oxidative status and reproductive hormones in male rabbits. Am. J. Anim. Vet. Sci., 8: 128-133. https://doi.org/10.3844/ajavsp.2013.128.133
El-Gayyar M, Draughon FA, Golden DA, Mount JR (2001). Antimicrobial activity of essential oils from plants against selected pathogenic and saprophytic microorganisms. J. Food. Protect., 64: 1019–1024. https://doi.org/10.4315/0362-028X-64.7.1019
El-Shafeey MEA, Taha TH (2013). Protective effect of oregano water extract against Carbon tetrachloride induced Hepatotoxicity in female rats. Egypt. Acad. J. Biol. Sci., 5(2): 67-76. https://doi.org/10.21608/eajbsc.2013.16096
El-Shenawy NS (2010). Effects of insecticides fenitrothion, endosulfan and abamectin on antioxidant parameters of isolated rat hepatocytes. Toxicol. Vitro, 24: 1148-1157. https://doi.org/10.1016/j.tiv.2010.03.001
El-Speiy ME, El-Sawy MA, Tony MA, Sadaka TA (2016). Comparative studies on reproductive male rabbits as affected by therapeutic of ivermectin or both of garlic and cinnamon oils treatments. b. biochemical blood, hormones and semen characteristics in male rabbit. Egypt. J. Rabbit Sci., 26(1): 57- 87. https://doi.org/10.21608/ejrs.2016.41872
El-Zoghby RR, Amin A, Hamouda FA, Ali A (2015). Toxicological and pathological studies of Ivermectin on male albino rats. J. Am. Sci., 11: 73-83.
EMA (European medicines agency), (2014). Committee for veterinary medicinal products for veterinary use,European public MRL assessment report, Ivermectin (all mammalian food producing species),EMA/CVMP/294840/2014.
Fleisher A, Fleisher Z (1988). Identification of Biblical Hyssop and origin of the traditional use of Oregano-group herbs in the Mediterranean region. Econ. Bot., 42: 232–241. https://doi.org/10.1007/BF02858924
Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18(6): 499-502. https://doi.org/10.1093/clinchem/18.6.499
González CA, Sahagún Prieto AM, Diez Liébana MJ, Fernández MN, Sierra VM, García Vieitez JJ (2008). The pharmacokinetics and interactions of ivermectin in humans-A mini-review. AAPSJ. 10: 42–46. https://doi.org/10.1208/s12248-007-9000-9
Govers R, Bevers L, De Bree P, Rabelink TJ (2002). Endothelial nitric oxide synthase activity is linked to its presence at cell-cell contacts. Biochem. J., 361(2): 193–201. https://doi.org/10.1042/0264-6021:3610193
Hoeflmayr J (1979). Praxis and Helferin. pp. 8.
Ismaiel SI, Sameh MF, Raafat AE, Waleed FK (2017). Ameliorative impacts of tribulus terrestris against ivermectin induced hepato-renal toxicity in rabbit: Pharmacological and histopathological study. Am. J. Anim. Vet. Sci., 12(1): 8-16. https://doi.org/10.3844/ajavsp.2017.8.16
Jin L, Feng X, Rong H, Pan Z, Inaba Y, Qiu L, Zheng W, Lin S, Wang R, Wang Z, Wang S, Liu H, Li S, Xie W, Li Y (2013). The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism. Nature Commun., 4(1): 1-8. https://doi.org/10.1038/ncomms2924
Khan S, Lakhe-Reddy S, Mc-Carty JH, Sorenson CM, Sheibani N, Reichardt LF, Kim JH, Wang B, Sedor JR, Schelling JR (2011). Mesangial cell integrin αvβ8 provides glomerular endothelial cell cytoprotection by sequestering TGF-β and regulating PECAM-1. Am. J. Pathol., 178(2): 609–620. https://doi.org/10.1016/j.ajpath.2010.10.031
Kokkini S (1997). Taxonomy, diversity and distribution of Origanum species. In: Padulosi S (eds.), Oregano, 14 Proceedings of IPGRI International workshop, Italy, Rome, pp. 2–12.
Kondo S, Scheef EA, Sheibani N, Sorenson CM (2007). PECAM-1 isoform-specific regulation of kidney endothelial cell migration and capillary morphogenesis. Am. J. Physiol. Cell. Physiol. 292(6): 2070-2083. https://doi.org/10.1152/ajpcell.00489.2006
Koukoulitsa C, Zika C, Hadjipavlou–Litina D, Demopoulos VJ, Skaltsa H (2006). Inhibitory effect of polar oregano extracts on aldose reductase and soybean lipoxygenase in vitro. Phytother. Res., 20: 605–606. https://doi.org/10.1002/ptr.1901
Kulisic T, Radonić A, Katalinic V, Milos M (2004). Use of different methods for testing antioxidative activity of Oregano essential oil. Food. Chem., 85: 633–640. https://doi.org/10.1016/j.foodchem.2003.07.024
Kumar P, Sahay MN, Sinha VK, Samantaray S (2002). Comparative efficacy of the some acaricides against mange in dog. Indian Vet. J., 79: 828–830.
Lee HP, Lin CY, Shih JS, Fong YC, Wang SW, Li TM, Tang CH (2015). Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-α pathway. Oncotarget, 6(34): 36746–36761. https://doi.org/10.18632/oncotarget.5479
Levitt DG, Levitt MD (2017). Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. Clin. Exp. Gastroenterol., 10: 147-168. https://doi.org/10.2147/CEG.S136803
Liu Z, Wang X, Wang Y, Zhao M (2017). NLRP3 inflammasome activation regulated by NF-κB and DAPK contributed to paraquat-induced acute kidney injury. Immunol. Res., 65: 687–698. https://doi.org/10.1007/s12026-017-8901-7
Mathachan SR, Sardana K, Khurana A (2021). Current use of ivermectin in dermatology, tropical medicine, and covid-19: an update on pharmacology, uses, proven and varied proposed mechanistic action. Indian Dermatol. Online J., 12(4): 500–514. https://doi.org/10.4103/idoj.idoj_298_21
Mellgren M, Bergvall K (2008). Treatment of rabbit cheyletiellosis with selamectin or ivermectin: A retrospective case study. Acta Vet. Scand., 50: 1-6. https://doi.org/10.1186/1751-0147-50-1
Ming L, Tian-Zi Y, Wen-Jun Z, Jian-Ping Q, Ci L, Bing Z, Shi-Wen X, Shu L (2013). Antioxidant response and histopathological changes in brain tissue of pigeon exposed to avermectin. J. Ecotoxicol., 22: 1241–1254. https://doi.org/10.1007/s10646-013-1112-7
Mitra J, Shikari RN, Das AK, Roy BB, Mitra M (2014). Therapeutic management of sarcoptic mange in rabbit with Ivermectin. Explor. Anim. Med. Res., 4(1): 116-120. https://doi.org/10.5455/ijlr.20130911093050
Muthuraman A, Sood S, Singla SK (2011). The anti-inflammatory potential of phenolic compounds from Emblica officinalis L. in rat. Inflammopharmacology, 19: 327-334. https://doi.org/10.1007/s10787-010-0041-9
Nashwa A, Abu Aita, Faten F, Mohammed (2014). Effect of marjoram oil on the clinicopathological, cytogenetic and histopathological alterations induced by sodium nitrite toxicity in rats. Glob. Vet., 12(5): 606-616.
Panigrahi PN, Gupta AR (2013). Therapeutic management of concurrent sarcoptic and psoropticacariasis in rabbits. Intas. Polivet., 14(11): 319-321.
Park S, Sorenson CM, Sheibani N (2015). PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis. Clin. Sci., 129(3): 217–234. https://doi.org/10.1042/CS20140714
Peace, AJ, Kaplan LA (1987). Clinical chemistery, Mosby st., Louis., USA.
Peixoto-Neves D, Silva-Alves KS, Gomes MD, Lima FC, Lahlou S, Magalhaes PJ, Ceccatto VM, Coelho-De-Souza AN, Leal-Cardoso JH (2010). Vasorelaxant effects of the monoterpenic phenol isomers, carvacrol and thymol, on rat isolated aorta. Fundam. Clin. Pharmacol. 24: 341–350. https://doi.org/10.1111/j.1472-8206.2009.00768.x
Pimple BP, Kadam PV, Patil MJ (2012). Comparative antihyperglycaemic and antihyperlipidemic effect of Origanum majorana extracts in NIDDM rats. Orient. Pharm. Exp. Med., 12: 41–50. https://doi.org/10.1007/s13596-011-0047-x
Puertas MM, Hille BS, Stashenko E, Winterhalter P (2002). In vitro radical scavenging activity of essential oils from columbian plants and fractions from oregano (Origanum vulagre L.) essential oil. flavor. Frag. J., 17: 380–384. https://doi.org/10.1002/ffj.1110
Rabab RE, Amin A, Hamouda AF, Ali A (2015). Toxicological and pathological studies of ivermectin on male albino rats. J. Am. Sci., 11: 73-83.
Rašković A, Pavlović N, Kvrgić M, Sudji J, Mitić G, Čapo I, Mikov M (2015). Effects of pharmaceutical formulations containing thyme on carbon tetrachloride-induced liver injury in rats. BMC Complement. Altern. Med., 15: 442. https://doi.org/10.1186/s12906-015-0966-z
Reitman S, Frankel S (1957). A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol., 28(1): 56–63. https://doi.org/10.1093/ajcp/28.1.56
Roby MHH, Sarhan MA, Selim KA, Khalel KI (2013a). Evaluation of antioxidant activity, total phenols and phenolic compounds in thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and marjoram (Origanum majorana L.) extracts. Ind. Crop. Prod., 43: 827–831. https://doi.org/10.1016/j.indcrop.2012.08.029
Roy S, Roy M, Dutta GK, Pal S, Tiwari SK (2001). Therapeutic evaluation of herbal preparations against demodecticmange infection in dogs. Indian Vet. J., 78: 629–630.
Schaffner F, Popper H (1963). Capillarization of hepatic sinusoids in man. Gastroenterology, 44(3): 239–242. https://doi.org/10.1016/S0016-5085(63)80130-4
Seddiek SA, Ali MM, Khater HF, El-shorbagy MM (2013). The acaricidal efficacy of aqueous neem extract and ivermectin against Sarcoptes scabiei var. cuniculi in experimentally infested rabbits. Parasitol. Res., 112: 2319-2330. https://doi.org/10.1007/s00436-013-3395-2
Selvakumar K, Bavithra S, Bhat FA, Krishnamoorthy G (2013). Effect of quercetin on hematobiochemical and histological changes in the liver of polychlorined biphenyls-induced adult male wister rats. J. Biomark., 2013: 1-12. https://doi.org/10.1155/2013/960125
Sharifi-Rigi A, Esfandiar H (2019). Therapeutic potential of Origanum vulgare leaf hydroethanolic extract against renal oxidative stress and nephrotoxicity induced by paraquat in rats. Avicenna J. Phytomed., 9(6): 563-573.
Shetty S, Lalor PF, Adams DH (2018). Liver sinusoidal endothelial cells gatekeepers of hepatic immunity. Nat. Rev. Gastroenterol. Hepatol., 15: 555–567. https://doi.org/10.1038/s41575-018-0020-y
Shoeb Q (2013). Biochemical toxicity of ivermectin in wistar albino rats. Am. Eur. J. Toxicol. Sci., 5: 15-19.
Shoop WL, Mrozik H, Fisher MH (1995). Structure and activity of avermectins and milbemycins in animal health. Vet. Parasitol., 59: 139-156. https://doi.org/10.1016/0304-4017(94)00743-V
Sivridis E, Giatromanolaki A, Touloupidis S, Pasadakis P, Vargemezis V (2003). Platelet endothelial cell adhesion molecule-1 and angiogenic factor expression in idiopathic membranous nephropathy. Am. J. Kidney. Dis., 41: 360–365. https://doi.org/10.1053/ajkd.2003.50044
Soliman AM, Elkomy A, El-Badwy M, Dina K (2019). Hepato-Renal protective effect of Organium majorana against paracetamol toxicity in rats. World J. Pharm. Pharm. Sci., 8(11): 36-49. https://doi.org/10.17582/journal.aavs/2020/8.4.385.391
Spinella R, Sawhney R, Jalan R (2016). Albumin in chronic liver disease: structure, functions and therapeutic implications. Hepatol. Int., 10(1): 124-132. https://doi.org/10.1007/s12072-015-9665-6
SPSS 20 (2011). IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp. (Released 2011).
Steel JW (1993). Pharmacokinetics and metabolism of avermectins in livestock. Vet. Parasitol., 48: 45-57. https://doi.org/10.1016/0304-4017(93)90143-B
Susztak K, Raff AC, Schiffer M (2006). Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes, 55(1): 225–233. https://doi.org/10.2337/diabetes.55.01.06.db05-0894
Suvarna KS, Layton CH, Bancroft JD (2012). Bancroft’s theory and practice of histological techniques: expert consult, online and print, the 7th edition Imprint, Churchill, Livingstone.
Zasz G (1974). Gamma-Glutamyltranspeptidase. In: Bergmeyer HU, Methoden der enzymatischen Analyse, Weinheim,Verlag Chemie,P:757
Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E (2011). Onchocerciasis: The Role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis and treatment. Clin. Microbiol. Rev. 24: 459-468. https://doi.org/10.1128/CMR.00057-10
Tietz NW (1976). Fundamentals of clinical chemistry, WB Saunders company, Philadelphia.
Tietz NW (1986). Textbook of clinical chemistry. WB saunders, Philadelphia, pp. 1919.
Tietz NW (1995). Clinical guide to laboratory tests, WB saunders, Philadephia, 3rd (eds), pp. 268-273.
Tietz NW, Pruden EL, Siggard-Andersen O (1994). Tietz textbook of Clin. Chem., WB Saunders Company, London, pp. 1354-1374.
Trailovic SM, Varagic VM (2007). The effect of ivermectin on convulsions in rats produced by lidocaine and strychnine. Vet. Res. Commun., 31: 863-872. https://doi.org/10.1007/s11259-007-0050-3
Trinder P (1951). A rapid method for the determination of sodium in serum. Analyst., 76: 596-599. https://doi.org/10.1039/an9517600596
Tsuneki M, Madri JA (2014). CD44 regulation of endothelial cell proliferation and apoptosis via modulation of CD31 and VE-cadherin expression. J. Biol. Chem., 289: 5357–5370. https://doi.org/10.1074/jbc.M113.529313
Wahlefeld AW (1974). Cloremetric determination of enzymatic triglycol in serum. In: M.M. Bermeyer (eds), Methodes of Enzymatic Analysis. Acad. Press, N. Y., 5: 1831-1835. https://doi.org/10.1016/B978-0-12-091304-6.50036-7
Walmsley RN, White GH (1994). Guide to diagnostic clinical chemistry, Blackwell Scientific Publications, Oxford, UK, 3rd ed., pp. 637.
Wanji S, Eyong EJ, Tendongfor N, Ngwa CJ, Esuka EN, Kengne-Ouafo AJ, Datchoua-Poutcheu FR, Enyong P, Agnew D, Eversole RR, Hopkins A, Mackenzie CD (2017). Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment PLoS. Negl. Trop. Dis., 11(7): 1-25. https://doi.org/10.1371/journal.pntd.0005576
Watson D (1960). A simple method for the determination of serum cholesterol. Clin. Chim. Acta, 5: 637-643. https://doi.org/10.1016/0009-8981(60)90004-8
Whealton A, Watson AJ, Rock RC (1994). Colorimetric determination of serum urea concentration. In: (eds. C.A. Burtis and E.R. Ashwood), Tietz Textbook of Clin. Chem., WB Saunders Company, London, pp. 1528-1531.
Wilkinson AL, Qurashi M, Shetty S (2020). The role of sinusoidal endothelial cells in the axis of inflammation and cancer within the liver. Front. Physiol., 11: 990. https://doi.org/10.3389/fphys.2020.00990
Wybenga DR, Digigorgio J, Piliggi VJ (1971). Automated method for urea measurement in serum. Clin. Chem., 97: 891-895. https://doi.org/10.1093/clinchem/17.9.891
Young DS (1997). Effects of drugs on clinical laboratory tests. Ann. Clin. Biochem., 34(6): 579-581. https://doi.org/10.1177/000456329703400601
To share on other social networks, click on any share button. What are these?